Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 20.80
-0.20 (-0.95%)
At close: Jan 12, 2026
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 922.37 million as of January 13, 2026. Its market cap has decreased by -14.75% in one year.
Market Cap
922.37M
Enterprise Value
941.69M
Revenue
455.25M
Ranking
n/a
PE Ratio
11.82
Stock Price
20.80
Market Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 322.34M to 922.37M, an increase of 186.15%. That is a compound annual growth rate of 10.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 922.37M | - |
| Dec 30, 2025 | 922.37M | -12.24% |
| Dec 30, 2024 | 1.05B | 1.72% |
| Dec 29, 2023 | 1.03B | 47.47% |
| Dec 30, 2022 | 700.64M | -18.47% |
| Dec 30, 2021 | 859.40M | 11.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.74B |
| Nordhealth AS | 2.83B |
| Photocure ASA | 2.02B |
| Thor Medical ASA | 1.83B |
| ArcticZymes Technologies ASA | 1.25B |
| Omda AS | 982.32M |
| Gentian Diagnostics ASA | 894.50M |
| Nykode Therapeutics AS | 745.18M |